Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report.

Clinical transplants

Volumn , Issue , 2010, Pages 391-396

  Schwaiger, Elisabeth ^a   Regele, Heinz ^b   Wahrmann, Markus ^b   Werzowa, Johannes ^b   Haidbauer, Bettina ^b   Schmidt, Alice ^b   Böhmig, Georg A ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BORONIC ACID DERIVATIVE; BORTEZOMIB; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PEPTIDE FRAGMENT; PROTEASOME; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE;

ARTICLE; BIOPSY; BLOOD; CASE REPORT; CHRONIC DISEASE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TIME; TREATMENT OUTCOME;

BIOPSY; BORONIC ACIDS; CHRONIC DISEASE; COMPLEMENT C4B; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNITY, HUMORAL; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960074244     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)